A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4+ CD25+ FOXP3+ Tregs that inhibit experimental autoimmune encephalomyelitis (EAE)
Abstract Background Tolerogenic vaccines represent antigen-specific interventions designed to re-establish self-tolerance and thereby alleviate autoimmune diseases, which collectively comprise over 100 chronic inflammatory diseases afflicting more than 20 million Americans. Tolerogenic vaccines comp...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12974-020-01856-8 |
id |
doaj-409f6255a29f4f4bb375295ceec8a6f7 |
---|---|
record_format |
Article |
spelling |
doaj-409f6255a29f4f4bb375295ceec8a6f72020-11-25T03:10:58ZengBMCJournal of Neuroinflammation1742-20942020-06-0117111910.1186/s12974-020-01856-8A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4+ CD25+ FOXP3+ Tregs that inhibit experimental autoimmune encephalomyelitis (EAE)Cody D. Moorman0Alexander G. Bastian1Kayla B. DeOca2Mark D. Mannie3Department of Microbiology and Immunology, Brody School of Medicine, East Carolina UniversityDepartment of Microbiology and Immunology, Brody School of Medicine, East Carolina UniversityDepartment of Microbiology and Immunology, Brody School of Medicine, East Carolina UniversityDepartment of Microbiology and Immunology, Brody School of Medicine, East Carolina UniversityAbstract Background Tolerogenic vaccines represent antigen-specific interventions designed to re-establish self-tolerance and thereby alleviate autoimmune diseases, which collectively comprise over 100 chronic inflammatory diseases afflicting more than 20 million Americans. Tolerogenic vaccines comprised of single-chain GM-CSF-neuroantigen (GMCSF-NAg) fusion proteins were shown in previous studies to prevent and reverse disease in multiple rodent models of experimental autoimmune encephalomyelitis (EAE) by a mechanism contingent upon the function of CD4+ CD25+ FOXP3+ regulatory T cells (Tregs). GMCSF-NAg vaccines inhibited EAE in both quiescent and inflammatory environments in association with low-efficiency T cell receptor (TCR) signaling events that elicited clonal expansion of immunosuppressive Tregs. Methods This study focused on two vaccines, including GMCSF-MOG (myelin oligodendrocyte glycoprotein 35–55/MOG35–55) and GMCSF-NFM (neurofilament medium peptide 13–37/NFM13–37), that engaged the transgenic 2D2 TCR with either low or high efficiencies, respectively. 2D2 mice were crossed with FOXP3 IRES eGFP (FIG) mice to track Tregs and further crossed with Rag −/− mice to reduce pre-existing Treg populations. Results This study provided evidence that low and high efficiency TCR interactions were integrated via CD40L expression levels to control the Treg/Tcon balance. The high-efficiency GMCSF-NFM vaccine elicited memory Tcon responses in association with activation of the CD40L costimulatory system. Conversely, the low-efficiency GMCSF-MOG vaccine lacked adequate TCR signal strength to elicit CD40L expression and instead elicited Tregs by a mechanism that was impaired by a CD40 agonist. When combined, the low- and high-efficiency GMCSF-NAg vaccines resulted in a balanced outcome and elicited both Tregs and Tcon responses without the predominance of a dominant immunogenic Tcon response. Aside from Treg expansion in 2D2-FIG mice, GMCSF-MOG caused a sustained decrease in TCR-β, CD3, and CD62L expression and a sustained increase in CD44 expression in Tcon subsets. Subcutaneous administration of GMCSF-MOG without adjuvants inhibited EAE in wildtype mice, which had a replete Treg repertoire, but was pathogenic rather than tolerogenic in 2D2-FIG-Rag1 −/− mice, which lacked pre-existing Tregs. Conclusions This study provided evidence that the GMCSF-MOG vaccine elicited antigenic responses beneath the CD40L triggering threshold, which defined an antigenic niche that drove dominant expansion of tolerogenic myelin-specific Tregs that inhibited EAE.http://link.springer.com/article/10.1186/s12974-020-01856-8FOXP3+ TregsImmune toleranceTolerogenic vaccineEAE/MSNeuroimmunologyGM-CSF |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cody D. Moorman Alexander G. Bastian Kayla B. DeOca Mark D. Mannie |
spellingShingle |
Cody D. Moorman Alexander G. Bastian Kayla B. DeOca Mark D. Mannie A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4+ CD25+ FOXP3+ Tregs that inhibit experimental autoimmune encephalomyelitis (EAE) Journal of Neuroinflammation FOXP3+ Tregs Immune tolerance Tolerogenic vaccine EAE/MS Neuroimmunology GM-CSF |
author_facet |
Cody D. Moorman Alexander G. Bastian Kayla B. DeOca Mark D. Mannie |
author_sort |
Cody D. Moorman |
title |
A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4+ CD25+ FOXP3+ Tregs that inhibit experimental autoimmune encephalomyelitis (EAE) |
title_short |
A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4+ CD25+ FOXP3+ Tregs that inhibit experimental autoimmune encephalomyelitis (EAE) |
title_full |
A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4+ CD25+ FOXP3+ Tregs that inhibit experimental autoimmune encephalomyelitis (EAE) |
title_fullStr |
A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4+ CD25+ FOXP3+ Tregs that inhibit experimental autoimmune encephalomyelitis (EAE) |
title_full_unstemmed |
A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4+ CD25+ FOXP3+ Tregs that inhibit experimental autoimmune encephalomyelitis (EAE) |
title_sort |
gm-csf-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the cd40l triggering threshold to expand cd4+ cd25+ foxp3+ tregs that inhibit experimental autoimmune encephalomyelitis (eae) |
publisher |
BMC |
series |
Journal of Neuroinflammation |
issn |
1742-2094 |
publishDate |
2020-06-01 |
description |
Abstract Background Tolerogenic vaccines represent antigen-specific interventions designed to re-establish self-tolerance and thereby alleviate autoimmune diseases, which collectively comprise over 100 chronic inflammatory diseases afflicting more than 20 million Americans. Tolerogenic vaccines comprised of single-chain GM-CSF-neuroantigen (GMCSF-NAg) fusion proteins were shown in previous studies to prevent and reverse disease in multiple rodent models of experimental autoimmune encephalomyelitis (EAE) by a mechanism contingent upon the function of CD4+ CD25+ FOXP3+ regulatory T cells (Tregs). GMCSF-NAg vaccines inhibited EAE in both quiescent and inflammatory environments in association with low-efficiency T cell receptor (TCR) signaling events that elicited clonal expansion of immunosuppressive Tregs. Methods This study focused on two vaccines, including GMCSF-MOG (myelin oligodendrocyte glycoprotein 35–55/MOG35–55) and GMCSF-NFM (neurofilament medium peptide 13–37/NFM13–37), that engaged the transgenic 2D2 TCR with either low or high efficiencies, respectively. 2D2 mice were crossed with FOXP3 IRES eGFP (FIG) mice to track Tregs and further crossed with Rag −/− mice to reduce pre-existing Treg populations. Results This study provided evidence that low and high efficiency TCR interactions were integrated via CD40L expression levels to control the Treg/Tcon balance. The high-efficiency GMCSF-NFM vaccine elicited memory Tcon responses in association with activation of the CD40L costimulatory system. Conversely, the low-efficiency GMCSF-MOG vaccine lacked adequate TCR signal strength to elicit CD40L expression and instead elicited Tregs by a mechanism that was impaired by a CD40 agonist. When combined, the low- and high-efficiency GMCSF-NAg vaccines resulted in a balanced outcome and elicited both Tregs and Tcon responses without the predominance of a dominant immunogenic Tcon response. Aside from Treg expansion in 2D2-FIG mice, GMCSF-MOG caused a sustained decrease in TCR-β, CD3, and CD62L expression and a sustained increase in CD44 expression in Tcon subsets. Subcutaneous administration of GMCSF-MOG without adjuvants inhibited EAE in wildtype mice, which had a replete Treg repertoire, but was pathogenic rather than tolerogenic in 2D2-FIG-Rag1 −/− mice, which lacked pre-existing Tregs. Conclusions This study provided evidence that the GMCSF-MOG vaccine elicited antigenic responses beneath the CD40L triggering threshold, which defined an antigenic niche that drove dominant expansion of tolerogenic myelin-specific Tregs that inhibited EAE. |
topic |
FOXP3+ Tregs Immune tolerance Tolerogenic vaccine EAE/MS Neuroimmunology GM-CSF |
url |
http://link.springer.com/article/10.1186/s12974-020-01856-8 |
work_keys_str_mv |
AT codydmoorman agmcsfneuroantigentolerogenicvaccineelicitsinefficientantigenrecognitioneventsbelowthecd40ltriggeringthresholdtoexpandcd4cd25foxp3tregsthatinhibitexperimentalautoimmuneencephalomyelitiseae AT alexandergbastian agmcsfneuroantigentolerogenicvaccineelicitsinefficientantigenrecognitioneventsbelowthecd40ltriggeringthresholdtoexpandcd4cd25foxp3tregsthatinhibitexperimentalautoimmuneencephalomyelitiseae AT kaylabdeoca agmcsfneuroantigentolerogenicvaccineelicitsinefficientantigenrecognitioneventsbelowthecd40ltriggeringthresholdtoexpandcd4cd25foxp3tregsthatinhibitexperimentalautoimmuneencephalomyelitiseae AT markdmannie agmcsfneuroantigentolerogenicvaccineelicitsinefficientantigenrecognitioneventsbelowthecd40ltriggeringthresholdtoexpandcd4cd25foxp3tregsthatinhibitexperimentalautoimmuneencephalomyelitiseae AT codydmoorman gmcsfneuroantigentolerogenicvaccineelicitsinefficientantigenrecognitioneventsbelowthecd40ltriggeringthresholdtoexpandcd4cd25foxp3tregsthatinhibitexperimentalautoimmuneencephalomyelitiseae AT alexandergbastian gmcsfneuroantigentolerogenicvaccineelicitsinefficientantigenrecognitioneventsbelowthecd40ltriggeringthresholdtoexpandcd4cd25foxp3tregsthatinhibitexperimentalautoimmuneencephalomyelitiseae AT kaylabdeoca gmcsfneuroantigentolerogenicvaccineelicitsinefficientantigenrecognitioneventsbelowthecd40ltriggeringthresholdtoexpandcd4cd25foxp3tregsthatinhibitexperimentalautoimmuneencephalomyelitiseae AT markdmannie gmcsfneuroantigentolerogenicvaccineelicitsinefficientantigenrecognitioneventsbelowthecd40ltriggeringthresholdtoexpandcd4cd25foxp3tregsthatinhibitexperimentalautoimmuneencephalomyelitiseae |
_version_ |
1724656024575541248 |